ArticleFrontiers in cardiovascular medicine2025
Efficacy analysis of the Tendvia™ pulmonary artery stent thrombectomy system in the treatment of intermediate- to high-risk pulmonary embolism.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multi-center Randomized Controlled Trial of Catheter-Directed Mechanical Thrombectomy Versus Systemic Thrombolysis in Patients with Acute Intermediate-to-High-Risk Pulmonary Embolism: Study Protocol.Cardiovascular and interventional radiology · 2026Article
- Zero anticoagulation, zero thrombolysis: successful management of massive pulmonary embolism following hemorrhagic transformation of acute ischemic stroke: a case report.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the clinical efficacy of the Tendvia™ pulmonary artery stent thrombectomy system in treating patients with intermediate-high risk and high-risk acute pulmonary embolism. Methods: A total of 15 consecutive patients with acute pulmonary embolism (classified as intermediate-high risk and high risk) admitted to Northeast Yunnan Central Hospital from January 2025 to March 2025 were enrolled. Among them, there were 7 male and 8 female patients, with a mean age of (65.2 ± 11.38) years. All patients underwent percutaneous mechanical thrombectomy (PMT) using the Tendvia™ pulmonary artery stent thrombectomy system. General patient information, including history of venous thromboembolism (VTE), surgical history within four weeks, and embolism locations, was recorded. Changes in pulmonary artery pressure before and after thrombectomy, as well as preoperative and postoperative ratios of right ventricular diameter to left ventricular diameter (RV/LV) on echocardiography, and relevant results from biochemical tests such as troponin, D-dimer, and N-terminal pro-B-type Natriuretic Peptide (NT-BNP), were compared. The improvement in right heart function, hemodynamic changes, and alterations in myocardial enzymes were evaluated to assess the safety and efficacy of the Tendvia™ pulmonary artery stent thrombectomy system Results: The surgical procedures were effective in all 15 patients, with no mortality reported. Pulmonary artery pressure significantly decreased after thrombectomy compared to preoperative levels, demonstrating statistical significance. Symptoms such as chest tightness, chest pain, and dyspnea were markedly alleviated in all patients. Conclusion: The Tendvia™ pulmonary artery stent thrombectomy system demonstrates definitive efficacy in treating intermediate-high risk and high-risk pulmonary embolism, with a low incidence of surgical complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.